Source: International Congress 2019 – From the health effects of tobacco to the epidemiology of tobacco/electronic nicotine delivery system use
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bajaj (London, United Kingdom), S. Ruickbie (London, United Kingdom), D. Burrage (London, United Kingdom), C. Spilling (London, United Kingdom), P. Jones (London, United Kingdom), E. Baker (London, United Kingdom), T. Barrick (London, United Kingdom). Relationship between markers of systemic inflammation and microstructural brain damage in COPD.. 3310

Member's Comments

No comment yet.

Related content which might interest you: The nature of inflammation and tissue damage in COPD Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD Year: 2004 Investigation of relationships between inflammation and brain disease in COPD Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities Year: 2018 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Effect of pulmonary rehabilitation on systemic inflammatory markers, muscle cross section area and functional parameters in interstitial lung disease Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Relationship between asthma and systemic inflammation Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Relationship between oxidative stress, endothelial injury and coagulation activation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 The relationship between bronchial inflammation and markers of disease progression in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 The lung parenchyma in COPD patients: in vitro mechanics and its correlation with inflammatory and structural changes Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD) Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Association of oxidative stress and inflammation with cardiovascular injury in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Relationship of airway structural changes and lung function abnormalities with blood and BAL biomarkers in asthma Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Effect of pulmonary rehabilitation on systemic inflammation, functional parameters and muscle cross section area in COPD Source: Annual Congress 2010 - Physical activity, exercise regimes and outcomes for chronic respiratory disease Year: 2010 The role of systemic markers of inflammation in bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Biochemical markers of connective tissue damage at chronic toxic fibrosing alveolitis Source: Eur Respir J 2006; 28: Suppl. 50, 99s Year: 2006